Goldman Sachs’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Goldman Sachs’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-16,700	Closed	-$1.71M	–	7614
2014 Q4	$1.71M	Sell	16,700 -60,600	-78%	-$5.81M	﹤0.01%	4005
2014 Q3	$6.69M	Sell	77,300 -10,300	-12%	-$912K	﹤0.01%	2736
2014 Q2	$7.9M	Buy	87,600 +61,800	+240%	+$4.62M	﹤0.01%	2583
2014 Q1	$1.9M	Sell	25,800 -46,700	-64%	-$3.26M	﹤0.01%	4010
2013 Q4	$4.94M	Sell	72,500 -9,000	-11%	-$586K	﹤0.01%	3091
2013 Q3	$4.97M	Buy	81,500 +16,640	+26%	+$1.02M	﹤0.01%	2924
2013 Q2	$3.61M	Buy	+64,860	New	+$3.75M	﹤0.01%	3071

Goldman Sachs's COV Position: Q1 2015 in Review

Goldman Sachs sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 2,623,849 shares — an estimated $268M sold.

Goldman Sachs first reported a position in COV in Q2 2013 and held it in 7 quarters. The position peaked at $269M in Q4 2013. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Goldman Sachs reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Goldman Sachs sold 2,623,849 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $268M.
Goldman Sachs first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 7 quarters.
Goldman Sachs's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $269M in Q4 2013.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.